Recent Updates
Recently added Catalysts
SRPT Positive Sentiment

Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Monday, August 31, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Sarepta Therapeutics announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference. Senior management will engage in a fireside chat on September 14 at 8:30 a.m. ET. The presentation will be available via live webcast and archived on the company's investor relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Sarepta Therapeutics is recognized as a leader in precision genetic medicine.
  • Participation in a prestigious healthcare conference highlights company visibility.
  • The event provides a platform for senior management to engage with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+46%
120-day peak, hindsight
Typical move
16.8%
average across 4 past catalysts
Lead asset
Eteplirsen
Phase 3 · Muscular Dystrophy, Duchenne

Full Press Release Details

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, Sept. 14, at 8:30 a.m. ET. The presentation will be webcast live under the investor relations section of Sarepta’s website at https://investorrelations.sarepta.com/events-presentations and will be archived there f

Frequently Asked Questions

When will Sarepta present at the conference?

Sarepta will present at the Morgan Stanley conference on September 14 at 8:30 a.m. ET.

Where can I watch the presentation?

The presentation will be webcast live on Sarepta's investor relations website.

Who from Sarepta will participate in the event?

Senior management from Sarepta Therapeutics will participate in the fireside chat.

Is the presentation available after the live event?

Yes, the presentation will be archived on Sarepta's investor relations website.

ShareAdd on Google
Tags: SRPT Viatris Investor Conferences Healthcare Sarepta Therapeutics Morgan Stanley healthcare conference genetic medicine
Last updated: Aug 31, 2026

Biotech snapshot

Cash runway
$788M liquidity · $0M/mo burn
Low dilution risk
Lead asset
EteplirsenPhase 3
Muscular Dystrophy, Duchenne →

Catalyst track record

+46%
best trade around SRPT's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for SRPT.

See every catalyst's timing & PoA →